Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Wyld Networks strengthens its commercial position with published patent application and secured trademarks

Satellite IoT company Wyld Networks strengthens its commercial position as the company’s first international patent application protecting Wyld’s cutting-edge technology has been published. In the strategic efforts to protect the company’s IP assets and long-term value, Wyld Networks has also secured key trademarks associated with the Wyld brand and products.“We are very pleased to have got our first international patent application published as well as having secured several key trademarks. As a growing tech company, our intellectual property is a strategic asset and – alongside the people

Preliminary figures show a positive EBITDA-result amounting to SEK 700,000 and a positive cash flow for the month of September

Preliminary figures show a positive EBITDA-result amounting to SEK 700,000 for the month of September. The continued good development of SpectrumOne together with rising revenues has led to the company generating a positive EBITDA result during September and a positive cash flow during the same month. The final figures will be reported in the upcoming q3-report on October 29 together with the numbers for July and August. Hosni Teque-Omeirat CEO of SpectrumOne commented on the preliminary figures  “We have since the start of the transformation of this company had several milestones and

Fimea inspected Nightingale’s regulatory compliance with the requirements for manufacturer of medical device

Press release, 14 October 2021 at 9:50 a.m. (EEST) The authority supervising regulatory compliance of medical devices and actors in the industry, Fimea, has as part of its market surveillance inspected Nightingale Health Plc’s (“Nightingale”) regulatory compliance with the requirements for manufacturer of medical device. The inspection included an evaluation of the manufacturer’s compliance with statutory obligations and required quality assurance, including among other things fulfillment of risk management, change management, document management, customer feedback management and control

Solstad Offshore, Aker Solutions and DeepOcean create offshore renewables alliance

October 14[th], 2021 – Solstad Offshore ASA (Solstad Offshore), Aker Solutions ASA (Aker Solutions) and DeepOcean Norway AS (DeepOcean) and have joined forces to create Windstaller Alliance. The new partnership aims to provide the world’s most cost-efficient and complete product supply, fabrication and marine services offering within offshore wind. The alliance will also pursue other offshore renewables segments. Windstaller Alliance will combine the already well-established capabilities and expertise of the three offshore industry leaders. This will form an integrated and highly

Genetic Analysis receives important patent allowance in China

OSLO, NORWAY - 14 October 2021: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company has been awarded an important patent (CN107430644A) by the China National Intellectual Property Agency (CNIPA). The patent entitled “A METHOD FOR DETERMINING GASTROINTESTINAL TRACT DYSBIOSIS” covers the Company’s unique algorithm incorporated in the GA-map® technology for profiling gut microbiota. The positive decision from the Chinese patent authority means that the protection of the GA-map® technology has been substantially strengthened and will further support the

Aker Solutions, DeepOcean and Solstad Offshore Create Offshore Renewables Alliance

October 14, 2021 – International offshore energy suppliers Aker Solutions, DeepOcean and Solstad Offshore have joined forces to create Windstaller Alliance. The new partnership aims to provide the world’s most cost-efficient and complete product supply, fabrication and marine services offering within offshore wind. The alliance will also pursue other offshore renewables segments.Windstaller Alliance will combine the already well-established capabilities and expertise of the three offshore industry leaders. This will form an integrated and highly flexible one-stop-shop provider. The alliance

Improved ESG risk rating for Balco Group

Balco has taken several important steps in its sustainability work. The targeted efforts now yield results in the form of an improved ESG risk rating. In Sustainalytics’ latest valuation of the company, Balco improves its ESG risk rating from 28.6 to 20.8.– It is positive that our focus on sustainability is also reflected in independent assessments. It is proof that the systematic work we conduct has an effect. We are of course not satisfied here, but our goal is to get below 20 next year and thus reach ESG risk rating “Low”, says Johan Fälth, sustainability manager at Balco Group. The

Cantargia receives positive EMA opinion for orphan designation of nadunolimab for treatment of pancreatic cancer

Cantargia AB today announced that the Committee for Orphan Medicinal Products (COMP) at the European Medicines Agency (EMA) has issued a positive opinion for orphan designation of nadunolimab (CAN04) for treatment of pancreatic cancer. The European Commission is now expected to grant the orphan designation. This provides a range of incentives in the continued clinical development of CAN04 in pancreatic cancer.The interleukin-1 receptor accessory protein (IL1RAP)-binding antibody CAN04 is Cantargia’s lead program and is investigated in multiple clinical trials evaluating combination with

Epiroc wins large mining equipment order in Turkey

Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, has won a large order for mining equipment from Eti Bakir in Turkey. The machines will be used to expand three underground copper mines while making the operations as productive and safe as possible.Eti Bakir, Turkey’s largest mining company, has ordered a variety of drill rigs, mine trucks and loaders. The equipment will be used at the Kastamonu Küre, Artvin Murgul and Siirt Madenköy mines. The equipment order is valued at approximately MSEK 140 and was booked in the third quarter 2021.

Sleep Cycle launches Sleep Boot Camp for business

October 14, 2021, Gothenburg - Sleep Cycle launches Sleep Boot Camp; a sleep training program for companies, tailored for everyday use, with the goal of improving sleep and health among employees.Sleep Cycle’s Boot Camp is a four-week long, web-based sleep program developed in collaboration with sleep researcher Frida Rångtell, Ph.D. and psychologist Li Åslund, Ph.D. Each week a new sleep-related topic is introduced and includes course material in the form of videos, articles, coaching, exercises and challenges. The program is designed so participants use the Sleep Cycle app to better

Inzile’s new main owner is introduced

Referring to the completed transaction announced on October 12, Ragnar Åhgren, Chairman of the Board of Inzile, is delighted to welcome eFashion Championship with its owner Enrique Banuelos as the new main shareholder. - As the owner of 100% of eFashion Championship I express my sincere gratitude to all the shareholders of Inzile - especially the founder of Inzile Ragnar Åhgren and Board Member Håkan Örtenholm (who introduced us) - who have unanimously supported the creation of the NEW INZILE, as well as to the current board and management team who have all my support, so that with total

KONE publishes January-September 2021 Interim Report on Thursday, October 28, 2021 at 12:30 p.m. EEST

KONE Corporation, press release, October 14, 2021 at 9.30 a.m. EEST Interim ReportKONE Corporation will publish its Interim Report for the January 1-September 30, 2021 accounting period on Thursday, October 28, 2021 at 12:30 p.m. EEST. The report will be available on www.kone.com after publishing. Press and analyst eventsA Microsoft Teams call for the press, conducted in English, will be held on Thursday, October 28, 2021 at 2:15 p.m. EEST. Journalists are kindly asked to sign up to media@kone.com by Wednesday, October 27, 2021, and they will receive a link to the call upon

Invitation to conference call, October 21 at 13:30 pm CET

Studsvik AB presents its Interim Report for the third quarter 2021 and hereby invites media and analysts to a conference call held in English on Thursday, October 21 at 13:30 CET.Studsvik’s Interim Report for the third quarter 2021 will be distributed at approximately 12:00 CET, October 21. As of this time, the report will also be available at www.studsvik.com. The call will be held in English, starting 13:30 CET. Please call at least ten minutes prior to the start of the conference call to avoid delay. Event title is: Studsvik Q3 2021. Conference ID is: 1876858 Description

One third of people globally feel more positive about their homes in the past 12 months, new IKEA research reveals

Eighth annual IKEA Life at Home Report shows how homes have helped and hindered mental health and wellbeing around the world during the pandemic.Live streamed table talk today at 14:00 CET. Register here   · 40 percent of people who felt more positive toward their home in the last 12 months also saw their mental health improve · To achieve better balance at home, people say relaxation (53 percent) and alone time (38 percent) are the most important activities · Family relationships have taken centre stage during the pandemic, but one

Read original

Raisio plc: Raisio's converted shares

Raisio plc  Stock Exchange Release, 14 October 2021   RAISIO'S CONVERTED SHARES   The Board of Directors of Raisio plc has decided in its meeting held on 23 September 2021 to convert a total of 37,192 restricted shares (series K) into free shares (series V). The decision has been entered in the Trade Register today, on 14 October 2021. The additional lot of free shares in question is admitted to trading on the Nasdaq Helsinki Ltd as of 15 October 2021.   Since the beginning of 2021, a total of 484,734 restricted shares of the company have been converted into free shares.

BioStock: Positive phase I data for Ultimovacs

Biotech company Ultimovacs continues to strengthen the clinical evidence for its universal cancer vaccine UV1. On Wednesday morning the company could announce positive results from a phase I study of UV1 in combination with the checkpoint inhibitor pembrolizumab. The combination, which was tested in patients with metastatic malignant melanoma, showed the very encouraging survival rate of 80 per cent after 24 months.Read the full article at biostock.se:https://www.biostock.se/en/2021/10/positive-phase-i-data-for-ultimovacs/ This is a press release from BioStock - Connecting Innovation &

Last chance to tender shares in the recommended voluntary offer for all outstanding shares in Bank Norwegian ASA

NOT FOR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA AND JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE PRIOR APPROVAL. FOR MORE INFORMATION ABOUT NORDAX'S VOLUNTARY OFFER, PLEASE SEE NORDAX'S FORMAL OFFER ANNOUNCEMENT, AVAILABLE AT: WWW.COLLABORATE-TO-SCALE.COM.Reference is made to the offer document dated 5 August 2021 (the "Offer Document") for the recommended voluntary offer by Nordax Bank AB (publ) ("Nordax" or the "Offeror") to acquire all outstanding shares (the "Shares") in Bank Norwegian ASA ("Bank Norwegian" or the "Company")

Diaverum develops breakthrough AI model to deliver step-change in Vascular Access thrombosis prevention

Diaverum, a leading global renal care service provider, has developed an artificial intelligence model to support the company’s physicians and nurses predict with a high degree of accuracy, episodes of vascular access thrombosis among haemodialysed patients. Simulations using Diaverum’s historical patient data predicted an average of 75% of actual cases that were not detected by best-in-class clinical assessments and monitoring systems.Vascular Access (VA) thrombosis is a major factor of suffering and increased mortality for chronic haemodialysis patients, with incidence ranging between 0.

NORDEN PUBLISHES PROSPECTUS IN CONNECTION WITH ADMISSION TO TRADING AND OFFICIAL LISTING OF ITS USD 100,000,000 BONDS

ANNOUNCEMENT NO. 73 - 14 OCTOBER 2021 Not for release, publication or distribution, directly or indirectly, in any jurisdiction in which such release, publication or distribution would be unlawful Dampskibsselskabet NORDEN A/S has today published a listing prospectus prepared in connection with the admission to trading and official listing on Nasdaq Copenhagen A/S’ regulated market of its USD 100,000,000 senior unsecured bonds. The bonds were issued on 28 June 2021 and are senior unsecured bonds with a yearly coupon of 3-months LIBOR plus 4.75% with quarterly interest payments and

Invitation to Electrolux Professional AB Q3 2021 presentation

Electrolux Professional AB will publish the Q3 2021 interim report for the period July – September 2021, on Thursday, October 28, at 08:00 CETA telephone conference will be held at 09:00 CET with Alberto Zanata, CEO and Fabio Zarpellon, CFO presenting the result, followed by a Q&A session. The presentation will be available on https://www.electroluxprofessional.com/corporate/Please use the following dial-in details to participate in the telephone conference: Sweden: +46 8 566 427 04United Kingdom: +44 333 300 9269United States: +1 833 526 8382 The telephone conference and

Vitec Software Group AB Interim report January - September 2021

Summary of interim period, January–September 2021 · Net sales SEK 1,150 million (951), an increase of 21% · Recurring revenues SEK 975 million (796), an increase of 22% including 9% organic · EBITA was SEK 327 million (247), with an EBITA margin of 28% (26) · Operating profit was SEK 213 million (158), with an operating margin of 18% (17) · Earnings per share before dilution SEK 4.55 (3.51) · Cash flow from operating activities SEK 430 million (375) Summary of interim period, July–September 2021 · Net sales SEK 380 million (321), an increase of 19% · Recurring

Fiskars to publish its Interim Report for January-September 2021 on October 29, 2021

Fiskars Corporation Press release October 14, 2021 at 9:00 (EEST)     Fiskars to publish its Interim Report for January-September 2021 on October 29, 2021   Fiskars Corporation will publish its Interim Report for January-September 2021 on October 29, 2021 at approximately 8:30 a.m. (EEST). The report will be available on the company's website www.fiskarsgroup.com after publication.   Webcast A webcast on the third quarter results will be held on October 29, 2021 at 11:00. It will be held in English and can be followed at: https://fiskars.videosync.fi/2021-q3-

Metso Outotec wins order for Foresight™ semi-mobile primary gyratory crushing plant at Codelco’s Radomiro Tomic operation

Metso Outotec Corporation’s press release on October 14, 2021, at 09:00 a.m. EESTMetso Outotec has signed an agreement with Codelco in Chile to design and supply a Foresight™ semi-mobile primary gyratory (SMPG) crushing plant for Codelco’s Radomiro Tomic operation. The value of the order is not disclosed. It has been booked in Minerals’ Q3/2021 orders received. Equipped with a Superior™ MKIII 60-110 primary gyratory crusher, apron feeder discharge and dust collection, the Foresight™ SMPG meets the highest demands in productivity and sustainability. It is part of Metso Outotec’s in-pit

UNION therapeutics announces enrollment of first patient in the OSIRIS Phase 2a study of oral orismilast for the treatment of mild to severe hidradenitis suppurativa

· OSIRIS is an investigator-led, proof-of-concept Phase 2 study of orismilast for the treatment of mild to severe hidradenitis suppurativa (HS) · HS is a scarring inflammatory skin disease with significant unmet treatment need · Orismilast is a next generation PDE4 inhibitor with broad anti-inflammatory properties also in development for the treatment of psoriasis and atopic dermatitis Hellerup, Denmark, 14 October 2021 – UNION therapeutics A/S, a privately-held, multi-asset, clinical stage, pharmaceutical company focused on immunology and infectious diseases, today announced the

There are no items matching the current filter
There are no more items matching the current filter
Back to top